• GSK reports Q1 sales decline pharmatimes
    July 13, 2018
    GlaxoSmithKline has booked a 2 percent dip in revenues for the first quarter to £7.2 billion, after results were hit by a “significant currency impact” and lower sales of prescription drugs.
  • Walmsley cuts back pipeline, calls for greater pharma success at GSK pharmaphorum
    July 27, 2017
    GlaxoSmithKline’s new chief executive Emma Walmsley has unveiled her strategy for the company, saying its pharma division must focus more on its key assets and deliver ‘full value’ from launches.
PharmaSources Customer Service